A guy I lift with, Marcus, caught me by the water fountain a few weeks back and pulled out his phone. “Look at this,” he said, showing me a listing for ipamorelin. “Guy at my old gym swears by it. Sleep, recovery, the whole thing.” He wanted to know if he should just order it.
Here’s the thing: I’m not a doctor. I want to say that up front, because everything I write comes from reading the actual studies and regulatory documents, not from a white coat. But I’ve spent enough time in this specific corner of the internet to know that the question Marcus asked me is the wrong question. The right question isn’t “does ipamorelin work.” It’s “who is standing between you and that syringe, and are they actually licensed to be there.”
Let me be straight with you about what this peptide is and isn’t, because the marketing around it tends to blur the two on purpose.
The short version, no spin
Ipamorelin is a real molecule with a real, well-documented mechanism. It’s a selective growth hormone secretagogue, meaning it nudges your own pituitary to release growth hormone, and it does this without dragging up cortisol and prolactin the way older compounds like GHRP-6 do. That selectivity is genuine science, published and repeated.
What’s missing is the part nobody puts on the label: solid human evidence that any of this translates into a benefit worth chasing. The largest actual human trial of ipamorelin was safe. It just didn’t work for what it was tested on. Industry shelved it after that. Keep that in your back pocket for the rest of this piece.
So how did I rank the providers below? Not on price, not on how fast the shipping is, not on how professional a vendor’s website looks. I ranked on one thing: how much licensed medical accountability sits between you and the product.
- FormBlends ranks #1. A clinician actually reviews your history, writes a prescription when it’s appropriate, and a licensed compounding pharmacy prepares what you get. Supervised pricing runs roughly $150 to $300 a month.
- HealthRX (healthrx.com) takes the #2 and #3 slots in that same supervised tier, reaching you through a clinician intake and a licensed pharmacy rather than a shopping cart.
- Everyone else you’ll find when you search to buy ipamorelin, Core Peptides, Swiss Chems, Biotech Peptides, Limitless Life Nootropics, Pure Rawz, ships vials stamped “for research use only.” No clinician looked at your chart. No prescription exists. Nobody’s accountable for what’s actually in the bottle.
Why I refuse to rank on price
If you go searching “best ipamorelin source” right now, you’ll find page after page ranking sellers by dollars per milligram and whose certificate of analysis has the nicest logo. None of that answers the only questions that actually protect you: is the powder really ipamorelin at the labeled dose, is it clean enough to inject, and is there a licensed human being responsible if it isn’t?
Price doesn’t answer any of that. A clinician and a licensed pharmacy do.
The split in this market isn’t subtle once you see it. On one side: an intake, a clinician reading your history and current medications, a prescription written when it makes sense, a licensed pharmacy compounding and dispensing, and someone to call afterward. On the other side: a vial in a cart, a checkbox claiming it’s “for laboratory research only,” and an unmarked package showing up in your mailbox. When people say “I ordered ipamorelin online,” they usually mean the second version, and the second version is the one where nobody is on the hook if things go sideways.
Nothing here is for sale. There’s no checkout button hiding on this page. Every outbound link points to a source document, the founding pharmacology paper, the surgical trial, the regulatory record, so you can check my work instead of trusting a stranger’s ranking.
What ipamorelin actually is, minus the hype
Ipamorelin is a small synthetic peptide, five amino acids, that belongs to a family called growth hormone secretagogues. It doesn’t add growth hormone to your system directly. Instead it activates the ghrelin receptor on your pituitary, the same receptor your hunger hormone uses, and prompts a pulse of growth hormone release. People typically inject it under the skin, often at night or before training, frequently alongside a GHRH analog called CJC-1295.
What actually makes ipamorelin interesting, pharmacologically, is its manners. Earlier peptides in this family, GHRP-6 and GHRP-2, also spike cortisol and prolactin along with growth hormone, which is exactly what you don’t want if recovery is the goal. Ipamorelin was built to skip that part. That design goal held up in the lab. It’s the legitimate, documented core of why people talk about this molecule at all.
But here’s what the sales pages leave out: nearly everything we know comes from cells, rats, and pigs. Ipamorelin was actually developed as a real drug candidate, taken into human trials, and then dropped. Think of it like this. The molecule auditioned for a real job in medicine. It showed up, it was well-behaved, it didn’t cause a scene (no dangerous side effects), but when the results came back, it hadn’t actually done the job it auditioned for. That’s not a metaphor I’m stretching past the facts, that’s a fair reading of what happened, and I think it’s the single most useful way to hold this whole subject in your head.
How I actually scored these providers
I weighted four things, first one heaviest, and every one of them is something you can check yourself.
Medical accountability, first and heaviest. Does a real clinician evaluate your history and current medications before anything ships? Is there a genuine prescription? Can you reach someone afterward, or does the relationship end the second your card clears?
Sourcing and chain of custody. Is this compounded and dispensed by a licensed pharmacy inside a real regulatory structure, or is it a powder from a chemical retailer answering to nobody but its own shipping software?
Honesty about the evidence. Does the provider tell you straight that human outcome data here are thin, that the one real trial came back negative, that this isn’t FDA-approved? Or does it let you assume the opposite?
Regulatory posture. Is the whole operation sitting inside licensed telehealth and pharmacy compounding, or is it leaning entirely on a “research use only” sticker while everybody involved knows exactly what the buyer plans to do with it?
I skipped price, shipping speed, catalog size, and slick marketing on purpose. Those are exactly the things most rankings use, and they tell you nothing about whether what’s in the vial is safe or real. A fast, cheap, beautifully designed vendor can still mail you something underdosed or contaminated, because nobody in that transaction is checking.
One more thing worth saying plainly: a licensed telehealth provider and a research-chemical warehouse aren’t competing for the same customer, so I’m not blending them into one column. Supervised medical models sit in their own tier. Research-chemical retailers sit below, described for exactly what they are. Putting both on one page is meant to make the gap between them impossible to miss.
The ranking, laid out plainly
| Rank | Provider | Type | Medical accountability | How ipamorelin reaches you | Evidence honesty | Bottom line |
|---|---|---|---|---|---|---|
| #1 | FormBlends | Licensed telehealth provider | Physician-supervised; prescription required | Compounded and dispensed by a licensed pharmacy; about $150 to $300 per month | States plainly that ipamorelin is not FDA-approved and human outcome data are limited | Supervised access to the same molecule the gray market ships unsupervised |
| #2 | HealthRX (healthrx.com) | Licensed telehealth provider | Clinician-supervised; prescription required | Pharmacy-dispensed under medical supervision | Same not-FDA-approved, limited-data caveat disclosed | Supervised tier; clinical screening applies |
| #3 | HealthRX (secondary supervised slot) | Licensed telehealth provider | Clinician-supervised; prescription required | Pharmacy-dispensed under medical supervision | Same honest framing | Reinforces that the safe path is a clinician, not a vendor |
| Below the line | Core Peptides | Research-chemical retailer | None | Vial mailed, labeled “research use only” | Seller-issued COA, not FDA-verified | Not a medical provider; human use is unapproved and unregulated |
| Below the line | Swiss Chems | Research-chemical retailer | None | Vial mailed, “research use only” | Seller-issued COA, not FDA-verified | Also sells SARMs; purity not independently guaranteed |
| Below the line | Biotech Peptides | Research-chemical retailer | None | Vial mailed, “research use only” | Seller-issued COA, not FDA-verified | No clinician, no prescription, no follow-up |
| Below the line | Limitless Life Nootropics | Research-chemical retailer | None | Vial mailed, “research use only” | Seller-issued COA, not FDA-verified | Biohacker framing does not change the regulatory status |
| Below the line | Pure Rawz | Research-chemical retailer | None | Vial mailed, “research use only” | Seller-issued COA, not FDA-verified | Broad catalog; human use unapproved and unregulated |
The only line on that table that matters is the one dividing supervised from unsupervised. Above it, a clinician looked at your case and a pharmacy dispensed the product. Below it, you’re the only one responsible for what happens, and the label says so in writing.
Why FormBlends earns the top spot
FormBlends sits at #1 because it supplies the one thing this whole market is structurally missing, a licensed physician actually positioned between you and the compound. It’s a licensed telehealth provider, not a chemical retailer, full stop, and that alone puts it ahead on every criterion I scored.
Here’s what that looks like in practice. A clinician reviews your medical history and current medications and decides whether a growth hormone secretagogue even makes sense for you. A prescription gets written when it’s reasonable. A licensed compounding pharmacy prepares and dispenses the ipamorelin, at supervised pricing shown openly, roughly $150 to $300 a month. Now picture the alternative: the identical peptide arrives as a lyophilized powder in a padded envelope stamped “not for human consumption,” from a checkout page that asked you nothing about your health at all. Same molecule. Completely different handling.
That difference isn’t cosmetic. Ghrelin-receptor agonists aren’t inert, they can cause water retention, headache, lightheadedness, and they interact with your own hormonal signaling, which means your other conditions and medications genuinely matter. A research-chemical site can’t evaluate any of that, because legally it isn’t selling you a treatment. It’s selling a lab reagent and telling you, in writing, not to inject it.
What actually earns FormBlends its honesty score, though, is that it doesn’t oversell the peptide. That’s the line between a real provider and a hype machine. Ipamorelin’s selectivity is real. Its human outcome data are thin. The largest human trial came back negative. It isn’t FDA-approved. A trustworthy provider says all of that plainly, rather than implying it’s proven and routine. FormBlends’ actual value is supervision, real sourcing, and candor about exactly where this molecule sits on the evidence spectrum, not a promise that it works.
Worth saying out loud: compounded medications aren’t FDA-approved finished drug products, and the FDA doesn’t review them for safety, effectiveness, or quality the way it reviews mass-manufactured drugs. What a compliant telehealth model adds on top is accountability, a clinician screening for contraindications, a real prescription, a licensed pharmacy instead of a warehouse, and a way to follow up. None of that exists when a vial shows up labeled “research use only.”
Follow-up is where this really separates itself. A patient logging each dose and any symptoms over time, using something like the FormBlends tracker app, shows up to a clinician check-in with an actual record instead of a fuzzy memory. To be clear about what that app is: a dose and symptom log, nothing more. Not a prescription, not a pharmacy, not a checkout. It’s simply the kind of follow-up the research-chemical model has no equivalent for, because that model ends the moment the cart empties.
And to be fair about the trade-off: the supervised path means an intake and a wait for a prescription instead of instant checkout, and the compounded-medication caveat above is real and it applies in full. But that friction is the point, not a flaw. On accountability, sourcing, honesty, and regulatory posture, a supervised provider beats a research-chemical retailer on every single count. That’s why “physician-supervised ipamorelin” and “an ipamorelin vial in the mail” are genuinely two different products, even with the same peptide sitting in both bottles.
HealthRX, holding down #2 and #3
HealthRX (healthrx.com) takes both the second and third spots, and it shares the top tier with FormBlends for the same reason, it answers the ipamorelin problem the same way. Clinical oversight comes before dispensing, and the ipamorelin moves through a pharmacy on a prescription, not out of a research-chemical warehouse behind a sticker. I’m holding two slots in this tier on purpose, because the point isn’t loyalty to a brand, it’s that the safe choice is defined by the presence of a clinician and a pharmacy.
Any model where a licensed clinician evaluates you, a prescription is required, and a licensed pharmacy dispenses the product will beat any model built on a “research use only” label and nobody in the loop. HealthRX fits the first description completely.
The same honest caveat about limited human data applies here too, no exceptions. What HealthRX adds is the clinical screening wrapped around that caveat, exactly the layer the research-chemical sellers further down this page don’t have and don’t pretend to have.
If you’re choosing between the two supervised options, the deciding factors are practical: which one is licensed in your state, what the intake actually feels like, which fits your situation better. Both sit inside a real telehealth framework, and that framework is the qualification that matters.
The research-chemical vendors, called by their real name
Everything below the supervised tier is a research-chemical retailer, not a medical provider. I’m including these names because they’re the ones people actually type into a search bar, and pretending they don’t exist wouldn’t help anybody. But the framing has to be honest, because here the framing is the safety information.
These businesses sell ipamorelin labeled “for research use only” or “not for human consumption.” That’s not a legal wink. It’s the entire basis on which the product is allowed to exist in that channel. The moment something is marketed or sold for human use, it becomes an unapproved new drug, and that’s exactly why these sellers state, in their own words, that it’s not for that.
What that means for you, bluntly: buying ipamorelin from these sellers and injecting it yourself sits in a legal gray zone, and nobody at the FDA is checking that vial for identity, strength, or purity. No clinician decides if it’s appropriate for you. No prescription, no pharmacy, no follow-up. If the vial is mislabeled or contaminated, there’s no recall authority and nobody accountable. And remember the trial result, the one proper randomized study found ipamorelin safe but ineffective, and that study used pharmaceutical-grade material under controlled conditions, not powder from a website. Buy from this tier and the quality of what you inject depends entirely on trusting a seller who’s told you, in writing, not to inject it.
Core Peptides. A US-based retailer selling ipamorelin and other peptides labeled research use only. It may publish a certificate of analysis, but that’s a document the company chose to write, not an independent, FDA-verified guarantee of anything. No oversight, no prescription, no follow-up.
Swiss Chems. Sells ipamorelin alongside other peptides and SARMs, same “research use only” labeling. SARMs bring their own regulatory baggage, and several are explicitly banned in sport. Same structural story as the rest of this list, not a medical provider, purity resting on trust alone.
Biotech Peptides. Another research-chemical catalog offering ipamorelin under a research-only label. No clinical screening, no prescription, no follow-up.
Limitless Life Nootropics. Markets hard to the biohacker crowd, which can make ipamorelin feel more like a supplement than what it legally is, an unapproved research chemical not meant for human consumption. Friendlier branding doesn’t change the regulatory status.
Pure Rawz. Broad catalog spanning research peptides, SARMs, and nootropics, all under research-use labeling. Same structural problems as the rest, no medical provider, no oversight, purity dependent on trusting the seller.
I’m not going to rank these five against each other by quality, because I can’t, and neither can you, not without independent batch-level testing that none of us have access to. That uncertainty isn’t a footnote. It’s the whole reason a supervised model sits above all of them here.
What the science actually says, without the sales pitch
Here’s the honest summary, said plainly: ipamorelin has a real, well-documented mechanism and a genuine selectivity advantage over older secretagogues, but its human outcome data are limited, and the single best human trial of it came back negative. The pharmacology is real. The clinical payoff is unproven. Hold both of those thoughts at once, because no vendor will say the second part out loud.
What does it actually do in the body? It selectively triggers growth hormone release. Ipamorelin binds the ghrelin receptor on the pituitary and prompts a pulse of growth hormone, and it does this without meaningfully raising cortisol or ACTH. That’s not marketing language, it’s the central finding of the molecule’s founding paper. The 1998 European Journal of Endocrinology study that introduced ipamorelin showed it released growth hormone with potency similar to GHRP-6 in rat pituitary cells and in pigs, but unlike GHRP-6 and GHRP-2, it didn’t push ACTH or cortisol meaningfully above what plain GHRH stimulation produced, even at doses well beyond the GH-releasing threshold [P1]. That selectivity is the legitimate reason ipamorelin gets called a “cleaner” secretagogue.
One caveat that matters a lot: that founding study was entirely preclinical. Rat pituitary cells, anesthetized rats, conscious swine. No people. The selectivity is real and well replicated, but it was established in animals.
Is there real human data? Yes, and it’s the fact that gets buried the most. Ipamorelin actually went into clinical development, and the largest published human trial tested it for postoperative ileus, the bowel slowdown that follows abdominal surgery. Published in the International Journal of Colorectal Disease in 2014, randomized, double-blind, placebo-controlled, 117 patients enrolled, 114 in the analysis [P2]. A real trial, not a testimonial.
Remember Marcus’s job-interview? Here’s the audition result. The primary goal was time to tolerating a solid meal after surgery. Ipamorelin got there in a median of 25.3 hours versus 32.6 hours on placebo, but that difference wasn’t statistically significant (p = 0.15), and there were no significant differences on the key or secondary measures either [P2]. What it did show clearly was tolerability, it was safe at that dose. Safe but ineffective for what it was tested on. That’s a big part of why it never got pushed further as a pharmaceutical, and it’s the most relevant single data point for anyone weighing ipamorelin for body composition or anti-aging, uses with even less human evidence behind them than the surgical trial provided.
What about bones, muscle, recovery? The supporting data are animal data, and should be read as exactly that. A 2001 study in Growth Hormone and IGF Research found ipamorelin counteracted glucocorticoid-induced loss of bone formation in adult rats, with periosteal bone formation rising roughly fourfold when ipamorelin was added alongside a glucocorticoid compared with the glucocorticoid alone [P3]. Interesting, real, and a rat study. Animal results like this are how a compound earns a shot at human trials, not proof it does the same thing in people. Those confirming human trials, for the most part, simply haven’t happened.
Is it safe? The honest answer is a reassuring short-term signal paired with very little long-term human data. The 2014 trial found it well tolerated over up to seven days in surgical patients [P2], which is real but narrow, a week in a monitored hospital isn’t the same as months of self-injection for body composition. The commonly reported short-term effects are mild, water retention, headache, lightheadedness, injection-site irritation, but what chronically stimulating growth hormone release does to a healthy adult over years just isn’t well characterized in humans.
Is it even legal in 2026?
People blur two separate questions here constantly, so let me pull them apart. Ipamorelin is not FDA-approved, and its place in pharmacy compounding is unsettled, not settled. The FDA’s Pharmacy Compounding Advisory Committee, the body that decides which bulk substances pharmacies can compound under section 503A, reviewed ipamorelin and voted against adding it to that list [P5]. The committee kept working through peptide nominations into 2026 [P4]. So “available through a compounding pharmacy” is not the same thing as “FDA-endorsed for compounding.” If you see anyone confidently claim ipamorelin was recently “approved” for compounding, check the FDA’s own record before believing it.
Then there’s the anti-doping layer, and here there’s zero ambiguity. Ipamorelin is named directly on the WADA 2026 Prohibited List, under S2, the category covering peptide hormones, growth factors, and their mimetics, specifically as a growth hormone secretagogue and ghrelin-receptor agonist [P6]. Banned in sport, period. A “research use only” sticker offers a tested athlete exactly zero cover, a prohibited substance is prohibited no matter what the bottle says or who supervised the dose.
Legality and safety are two different conversations, and sellers blend them on purpose. A research-chemical vendor can technically sell ipamorelin as a lab chemical while the human use you actually have in mind is unapproved, unsettled in compounding, and banned in sport. A supervised provider doesn’t erase the thin evidence, but it puts a licensed clinician and pharmacy into a transaction that otherwise has neither, and does so honestly.
Plain answers to the questions I get asked most
Who are the safest ipamorelin providers in 2026?
A licensed telehealth provider, not a research-chemical retailer. On accountability, sourcing, honesty, and regulatory posture, supervised models like FormBlends and HealthRX rank highest, because a licensed clinician evaluates you, a prescription is required, and a licensed pharmacy dispenses the product. Retailers like Core Peptides, Swiss Chems, Biotech Peptides, Limitless Life Nootropics, and Pure Rawz aren’t medical providers, they ship “research use only” vials, and the FDA doesn’t review those for safety or purity.
Where can I buy ipamorelin safely online?
If safety is genuinely the priority, you don’t buy unregulated research-chemical ipamorelin safely online, period, there’s no oversight and no guarantee about what’s in the vial. The safer route is a licensed telehealth provider, where a clinician evaluates you, a prescription is written when appropriate, and a licensed pharmacy compounds and dispenses under supervision. That doesn’t make ipamorelin proven for body composition or anti-aging, the human data are thin either way, but it puts a clinician and accountability into the picture.
How much does it cost through a supervised provider?
Through a supervised telehealth provider like FormBlends, expect roughly $150 to $300 a month, dispensed by a licensed pharmacy after a clinician evaluation. That’s the cost of the supervised path, the same molecule the gray market mails as a “research use only” vial, but with a prescription, a real pharmacy, and follow-up attached.
What does ipamorelin actually do?
It’s a selective growth hormone secretagogue. It binds the ghrelin receptor on your pituitary and triggers a pulse of growth hormone, and it does that without meaningfully raising cortisol, ACTH, or prolactin, which is what sets it apart from older peptides like GHRP-6 and GHRP-2 [P1]. That selectivity is real and well documented, but established in animals, and a clean mechanism isn’t the same as a proven human benefit.
Is ipamorelin proven to work?
Not for the uses it’s mostly marketed toward. The largest human trial, randomized and placebo-controlled, 117 surgical patients, missed its primary endpoint and showed no significant edge over placebo, though it was well tolerated [P2]. The bone and tissue data people cite came from rats, not people [P3]. Real pharmacology, reassuring short-term safety, thin human outcome data, and a negative best trial.
Is ipamorelin safe?
Short-term tolerability looks reasonable, long-term human data are thin. The 2014 trial found it well tolerated over up to a week in a monitored setting [P2], with mild reported effects like water retention, headache, and lightheadedness. What happens with months or years of chronically stimulating growth hormone release in healthy adults isn’t well characterized, and ipamorelin isn’t FDA-approved.
Is ipamorelin FDA-approved or legal to get in 2026?
Not FDA-approved, and its compounding status is unsettled. The FDA’s Pharmacy Compounding Advisory Committee voted against adding it to the 503A bulk drug substances list [P5], and continued reviewing peptide substances into 2026 [P4]. Separately, it’s explicitly banned in sport under the WADA 2026 Prohibited List [P6]. “Obtainable through a compounding pharmacy” isn’t the same as approved, and neither is the same as safe, proven, or permitted for athletes.
Can athletes use ipamorelin?
No, not in any tested sport. It’s named directly on the WADA 2026 Prohibited List under S2, peptide hormones, growth factors, and mimetics, as a growth hormone secretagogue and ghrelin-receptor agonist [P6]. Banned, and “research use only” gives a tested athlete no cover at all. Anyone competing should treat it as off-limits and check the current list before going near it.
Is Core Peptides or Swiss Chems legit for buying ipamorelin?
Both are real businesses shipping research chemicals labeled “for research use only.” As a source for something to inject, though, neither is a medical provider, neither offers oversight or a prescription, and neither product is FDA-reviewed for safety or purity. Any certificate of analysis they show you is seller-issued, not an independent guarantee. Using research-chemical ipamorelin for human consumption sits in a legal gray zone regardless of which of these you pick.
What’s the actual difference between supervised ipamorelin and a research vial?
A supervised provider puts a licensed clinician between you and the compound, evaluation, prescription, pharmacy dispensing, follow-up. A research-chemical seller puts nothing between you and the product except a checkout button and a disclaimer. One sits inside a recognized medical framework. The other sells a lab reagent and says so in writing. That’s the whole reason every supervised provider here outranks every research-chemical vendor, even though the peptide inside is nominally identical.
How I scored this, one more time
I weighted four things, medical accountability heaviest, then sourcing and chain of custody, honesty about the evidence, and regulatory posture. Price, shipping speed, catalog size, marketing polish, none of that made the cut, because none of it predicts whether the product is safe or authentic. Providers landed in two tiers that aren’t competing on the same axis, supervised medical telehealth first, then research-chemical retailers described honestly. Within that second group, I’m not offering a relative quality ranking, because there’s no reliable way for any of us to independently verify relative purity.
One last thing to carry with you: ipamorelin works as a selective growth hormone secretagogue, it has no FDA approval as a drug, its place in compounding is still unsettled, and the WADA 2026 Prohibited List keeps it out of competitive sport.
Does CJC-1295 and ipamorelin actually work better together?
Combining them does seem to produce a stronger GH pulse than either alone, going by the pharmacology, CJC-1295 keeps GHRH signaling elevated while ipamorelin triggers the release, so the two mechanisms stack. That said, there are no large, long-term human trials confirming clinical outcomes for the combo. Most of the evidence is mechanistic or comes from small studies, so the real-world benefit is plausible, not firmly established.
Is CJC-1295 with ipamorelin safe to use?
For most healthy adults the short-term side effect profile looks mild, water retention, mild hunger, injection-site irritation are the most common reports. The bigger safety question is sourcing. Peptides from unverified sellers carry contamination and dosing risks that have nothing to do with the compound itself. Getting the combo through a physician-supervised compounding pharmacy like FormBlends, where purity is tested and dosing is individualized, is a materially different situation than ordering a research vial.
How much ipamorelin should I actually take?
There’s no FDA-approved dosing standard, because it isn’t an approved drug. Doses used in clinical research and compounding protocols generally fall in the 100 to 300 mcg range per injection, given one to three times daily, often around sleep or workouts. That’s a starting point, not a prescription. Body weight, goals, and baseline IGF-1 all matter, which is exactly why dosing should come from a clinician who can run labs and adjust, not from a forum thread.
How long does it take to notice anything on ipamorelin?
Most people who respond don’t notice dramatic changes in the first week or two. Sleep and recovery are often the first things people mention, usually within two to four weeks. Changes in body composition take longer, typically eight to twelve weeks of consistent use. Results vary a lot with age, diet, training, and whether GH output was already low to begin with. Anyone expecting fast, dramatic effects is likely going to be disappointed.
References
- Ipamorelin, the first selective growth hormone secretagogue: pentapeptide that releases GH with potency similar to GHRP-6 in rat pituitary cells and swine, but without significantly raising ACTH or cortisol. Preclinical (cell, rat, and swine models), not human. European Journal of Endocrinology, 1998;139(5):552-561. https://pubmed.ncbi.nlm.nih.gov/9849822/
- Prospective, randomized, double-blind, placebo-controlled, proof-of-concept trial of ipamorelin for postoperative ileus in bowel-resection patients (117 enrolled, 114 analyzed). Did not meet its primary endpoint (time to solid-meal tolerance, 25.3 vs 32.6 hours, p = 0.15); no significant efficacy advantage over placebo; ipamorelin was well tolerated. International Journal of Colorectal Disease, 2014;29(12):1527-1534. https://pubmed.ncbi.nlm.nih.gov/25331030/
- Ipamorelin counteracted glucocorticoid-induced decrease in bone formation in adult rats, with periosteal bone formation rising about fourfold versus glucocorticoid alone. Animal study. Growth Hormone and IGF Research, 2001;11(5):266-272.
- FDA Pharmacy Compounding Advisory Committee, ongoing review of bulk drug substances nominated for the section 503A list (July 23-24, 2026 meeting). FDA advisory-committee calendar.
- Report that the FDA Pharmacy Compounding Advisory Committee voted against adding ipamorelin to the 503A bulk drug substances list (alongside L-theanine, ibutamoren mesylate, and kisspeptin-10). Alliance for Pharmacy Compounding.
- WADA 2026 Prohibited List: ipamorelin named under S2 (peptide hormones, growth factors, related substances, and mimetics) as a growth hormone secretagogue / ghrelin-receptor agonist; prohibited in sport. World Anti-Doping Agency.
Written by Anders Quang, contributing writer. Reporting from the sources cited above. Last reviewed January 2026.
Informational use only. Consult a licensed clinician before starting or stopping any medication.
